Abiopharma

🔍 Johnson Stephen L (Executive)

Company: American Airlines Group Inc. (AAL)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Sold 30,000 shares of Common Stock at $15.2626 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 1,968,357.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 30,000 shares of Common Stock at $15.293 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 1,938,357.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: This sale was effected in connection with tax planning, and the proceeds from the transaction are being used to help satisfy tax obligations of the Reporting Person.
• F2: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from $14.90 to $15.44 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from $15.18 to $15.4408 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.